The Global Point of Care (POC) Molecular Diagnostics Market to witness tremendous Growth during the forecast period from 2022 to 2030
Point-of-care (POC) molecular diagnostics refers to tests that detect the presence of specific nucleic acids in clinical specimens such as stool, saliva, urine, blood, and tissue. This molecular diagnosis is based on looking at a target portion of the microbial genetic material, DNA or RNA. In the medical field, it detects emergency use rights for disease diagnosis. Point-of-care (POC) molecular diagnostics detect disease antigens or antibodies in human samples such as mononucleosis, influenza, and group A streptococci (GAS).
Point-of-care molecular diagnostics' primary products and services are assays and kits, instruments and analyzers, software, and services. Assays and kits refer to equipment used to perform assays such as disease pathway studies. Assays and kits have been widely used to quickly and accurately diagnose and monitor various diseases. Reverse transcription polymerase chain reaction (RT-PCR), in situ hybridization, and sequencing have been used for respiratory disease, hospital-acquired infection (HAI), cancer/oncology, hepatitis, and hematology. Distributed laboratories, hospitals, home care, and assisted living care facilities use point-of-care molecular diagnostics.
Market Dynamics:
Drivers:
Infectious diseases and rising incidence of acute and chronic diseases are some of the major factors propelling the market growth. For example, the increasing prevalence of cancer and HIV/AIDS directly impacts the market growth rate. According to the Department of Health & Human Services, more than XX million people were suffering from HIV AIDS in 2019.
Increased research and development proficiency spending, especially in developed and developing countries related to medical devices and devices, will further create lucrative market growth opportunities. Research and development capabilities carried out to develop emergency medical services are also bolstering the point of care (POC) molecular diagnostics market growth rate.
Restraints:
On the other hand, high costs associated with research and development capabilities, limited infrastructure facilities, and lack of awareness of backward economies are expected to hamper the market growth. Additionally, there is a lack of favorable reimbursement scenarios and technology penetration in developing countries, stringent regulatory hurdles associated with point-of-care diagnostic test kits, a lack of alignment with definitive central laboratory methods, and a lack of adequate infrastructure in low- and middle-income countries. It is expected to challenge the point of care (POC) molecular diagnostics market in the forecast period of 2022-2030.
Key players:
-
Abbott Laboratories
-
F. Hoffmann-La Roche Ltd.
-
bioMérieux SA
-
Danaher Corporation
-
Quidel Corporation
-
QIAGEN N.V.
-
Co-Diagnostics, Inc.
-
Biocartis NV
-
Meridian Bioscience, Inc.
-
Thermo Fisher Scientific, Inc.
-
Lucira Health, Inc.
-
Cue Health
-
OpGen, Inc.
-
Binx Health, Inc.
-
Molbio Diagnostics Pct. Ltd.
-
Genomadix
-
Visby Medical, Inc.
-
QuikPath PTE Ltd.
-
MD-Bio
-
QuantuMDx Group Ltd.
-
Aidian Oy
-
GeneSTAT Molecular Diagnostics, LLC
Market Segmentation:
Point of Care (POC) Molecular Diagnostics Market, By Product & Service
-
Assays & kits
-
Instruments & Analyzers
-
Software & Services
Point of Care (POC) Molecular Diagnostics Market, By Technology
-
RT-PCR
-
INAAT
-
Other technologies
Point of Care (POC) Molecular Diagnostics Market, By Application
-
Respiratory Diseases
-
Sexually Transmitted Diseases
-
Hospital-acquired Infections
-
Cancer
-
Hepatitis
-
Gastrointestinal Disorders
-
Other Applications
Point of Care (POC) Molecular Diagnostics Market, By End User
-
Physicians’ Offices
-
Hospitals & ICUs
-
Research Institutes
-
Other End Users
Point of Care (POC) Molecular Diagnostics Market, By Region
-
North America
-
US
-
Canada
-
-
Europe
-
UK
-
Germany
-
France
-
Italy
-
Rest of Europe (RoE)
-
-
Asia Pacific
-
China
-
Japan
-
India
-
Rest of Asia Pacific (RoAPAC)
-
-
Rest of the World (RoW)
Regional Analysis:
Ongoing efforts by key market players to strengthen their market position are important factors contributing to their key share. In addition, many clinical studies examining the efficiency and accuracy of new molecular tests are also expected to contribute to the point of care (poc) molecular diagnostics market growth during the forecast period.
The European region has emerged as a key market space due to the growing demand for rapid diagnostics and the development of modern molecular diagnostic tests for DNA analysis.
However, Asia Pacific is expected to witness the fastest growth during the forecast period due to the lack of sophisticated central laboratory testing services, a larger population base requiring clinical testing, and the potential cost-effective implementation of PoC molecular testing.
Scope of the Report:
Report Metric |
Details |
Market Size Available for Years |
2020–2030 |
Base Year Considered |
2020 |
Forecast Period |
2021–2030 |
Forecast Unit |
Value (USD) |
Segments Covered |
Offering, Technology, Application, End-User, and Region |
Regions Covered |
North America, Europe, Asia-Pacific, and LAMEA |
Companies Covered |
Abbott Laboratories, F. Hoffmann-La Roche Ltd., bioMérieux SA, Danaher Corporation, Quidel Corporation, QIAGEN N.V., Co-Diagnostics, Inc., Biocartis NV, Meridian Bioscience, Inc., Thermo Fisher Scientific, Inc., Lucira Health, Inc., Cue Health, OpGen, Inc., Binx Health, Inc., Molbio Diagnostics Pct. Ltd., Genomadix, Visby Medical, Inc., QuikPath PTE Ltd., MD-Bio, QuantuMDx Group Ltd., Aidian Oy, GeneSTAT Molecular Diagnostics, LLC |
User
Tab Content
Introduction
Our market research is an extensive, iterative process that takes into account a combination of primary and secondary research tools with the aim of minimizing deviation and producing the most precise estimate and prediction. For the future course of action, this approach meticulously outlines the actual changes and industry trends. It gives incredibly valuable data that is drawn from the insights and opinions of analysts and professionals. Our papers include in-depth research and analysis based on several factual inputs obtained from expert interviews, accurate data, and local information.

Market Size Estimation
The overall size of the market has been estimated and validated using both top-down and bottom-up methods. The sizes of other market subsegments have also been thoroughly estimated using these methodologies.

In the top-down technique, the market is divided into segments based on the percentage share of each segment. This method assisted in determining the size of each segment's market. The market size of each segment and its sub-segments was then divided into regional market sizes. This Approach helps mainly with the new Product Launch. It uses Multi-variate Regression Model coupled with Vendor based primary research inputs to forecast to the Market Size.
In the Bottom-Up approach, comprehensive study of key players has to be done wherein we add the market size of the major key players to understand the national market size which helps to determine the regional market size and eventually the complete market size. Companies annual report along with data from paid and unpaid resources like reports from government agencies and organizations like world bank provide the data for this approach.
Avail 25% Discount
Report Benefits
-
Free Customization Available
-
30% discount on your next purchase
-
Dedicated account manager
-
Query resolution within 24 hours
-
Permission to print the report